Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v2-EN
Language French English
Date Updated 2023-11-10 2023-11-10
Drug Identification Number 00393711 00393711
Brand name ISOCAINE HCL INJ 2% ISOCAINE HCL INJ 2%
Common or Proper name Mepivacaine Hydrochloride and Corbadrine (Levonordefrin) Injection Mepivacaine Hydrochloride and Corbadrine (Levonordefrin) Injection
Company Name NOVOCOL PHARMACEUTICAL OF CANADA INC NOVOCOL PHARMACEUTICAL OF CANADA INC
Ingredients CORBADRINE MEPIVACAINE HYDROCHLORIDE CORBADRINE MEPIVACAINE HYDROCHLORIDE
Strength(s) 0.05MG 20MG 0.05MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size Box of 50 Cartridges of 1.8mL each Box of 50 Cartridges of 1.8mL each
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2023-11-09 2023-11-09
Remaining supply date 2024-07-31 2024-07-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments